{"id":531,"date":"2026-04-22T11:21:37","date_gmt":"2026-04-22T15:21:37","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=531"},"modified":"2026-04-22T11:21:38","modified_gmt":"2026-04-22T15:21:38","slug":"the-healthcare-class-action-review-2026-a-deep-dive-into-healthcare-litigation-trends","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2026\/04\/22\/the-healthcare-class-action-review-2026-a-deep-dive-into-healthcare-litigation-trends\/","title":{"rendered":"The Healthcare Class Action Review \u2013 2026: A Deep Dive Into Healthcare Litigation Trends"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">By <a href=\"https:\/\/www.duanemorris.com\/attorneys\/geraldmaatman.html\">Gerald L. Maatman, Jr.<\/a> and <a href=\"https:\/\/www.duanemorris.com\/attorneys\/jenniferriley.html\">Jennifer A. Riley<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>The Healthcare Class Action Review \u2013 2026<\/em>\u00a0is a comprehensive new eBook that examines the most significant developments in healthcare-related class actions over the past year. Healthcare organizations today operate at the intersection of regulation, innovation, and patient expectations. Class action litigation involving healthcare companies, including hospitals, healthcare providers, pharmaceutical companies, biotechnology firms, medical device and health technology companies, and diagnostic and testing companies has evolved from a peripheral phenomenon into a central feature of complex class action litigation. The\u00a0<em>Healthcare Class Action Review \u2013 2026<\/em>\u00a0offers a clear, structured analysis of these trends, helping legal professionals, compliance teams, and industry leaders stay informed and prepared.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Download your copy of <a style=\"font-style: italic\" href=\"https:\/\/online.flippingbook.com\/view\/725793630\/\">The Healthcare Class Action Review \u2013 2026<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Gerald L. Maatman, Jr. and Jennifer A. Riley The Healthcare Class Action Review \u2013 2026\u00a0is a comprehensive new eBook that examines the most significant developments in healthcare-related class actions over the past year. Healthcare organizations today operate at the intersection of regulation, innovation, and patient expectations. Class action litigation involving healthcare companies, including hospitals, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2026\/04\/22\/the-healthcare-class-action-review-2026-a-deep-dive-into-healthcare-litigation-trends\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;The Healthcare Class Action Review \u2013 2026: A Deep Dive Into Healthcare Litigation Trends&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[600,727,221],"ppma_author":[521],"class_list":["post-531","post","type-post","status-publish","format-standard","hentry","category-general","tag-healthcare","tag-healthcare-class-action-review-2026","tag-life-sciences"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","author_category":"1","last_name":"Sullivan","first_name":"Margaret","job_title":"","user_url":"http:\/\/www.duanemorris.com","description":"<a href=\"http:\/\/www.duanemorris.com\">Visit the Duane Morris website.<\/a>"}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=531"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/531\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=531"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}